Amsterdam — October 8, 1999 — Sciton, Inc. announced today at EADV that the Contour Resurfacing laser has been awarded a CE Mark. CE Mark is a regulatory requirement to market and sell the Contour laser in Europe.
Contour, which is manufactured by Sciton Inc. has been widely accepted as the market leader in skin resurfacing, with unique technology that allows the physician to select the treatment parameters in relevant clinical units – microns of depth.
Treatment depth can now be varied to suit individual patient needs, therefore achieving the desired results while minimizing the healing time. According to Dan Negus, President of Sciton Inc., “Now that Contour has been awarded a CE Mark, it confirms the safety and quality of the laser and allows Sciton Inc. to provide the same unique technology to European Physicians.” “In 1998, Sciton revolutionized the skin resurfacing market with the introduction of the Contour™ dual-mode long pulse erbium laser that allows physicians to independently select the depth of ablation and coagulation. Physicians are able to choose the depth of treatment required to achieve effective results in measurements of microns of tissue, resulting in an extremely repeatable and uniform treatment.
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.